Literature DB >> 8093641

Unconventional processing of the 3' termini of the Epstein-Barr virus DNA polymerase mRNA.

F B Furnari1, M D Adams, J S Pagano.   

Abstract

Northern blot analysis of the Epstein-Barr virus DNA polymerase mRNA identified two discrete sizes of virally encoded polymerase transcripts, 5.08 kb detected in strains P3HR1, Raji, W-91, and FF-41 and 3.7 kb detected solely in the prototype B95-8 strain. 3' S1-nuclease mapping and analysis of cDNA sequence generated by RNA-based PCR demonstrated that the 3.7-kb polymerase mRNA from B95-8 terminates 484 base pairs downstream of the open reading frame in a region of the genome remarkable for its lack of an apparent polyadenylylation signal. Moreover, between the cleavage point and the poly(A) tract of the cDNAs are a series of inserted nucleotides, mostly adenosine and uridine residues of unknown origin. A similar analysis of the 3' terminus of the 5.0-kb mRNA from the other cell lines revealed that polyadenylylation occurs 1.4 kb downstream of the B95-8 terminus. This region is deleted in B95-8, which accounts for the alternate upstream terminus used in B95-8. Like the 3.7-kb terminus, the 5.0-kb terminus lacks a canonical polyadenylylation signal, but contains a rarely used UAUAAA sequence 32 bp upstream of the poly(A) tail. These results indicate that the mRNA encoded by the Epstein-Barr virus DNA polymerase gene is polyadenylylated at two different termini without the use of canonical signals, raising the possibility of involvement of a virus-encoded factor in 3' processing of this message.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8093641      PMCID: PMC45665          DOI: 10.1073/pnas.90.2.378

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Regulation of the Epstein-Barr virus DNA polymerase gene.

Authors:  F B Furnari; M D Adams; J S Pagano
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

2.  Pathways of activation of the Epstein-Barr virus productive cycle.

Authors:  A J Sinclair; M Brimmell; F Shanahan; P J Farrell
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

3.  Sequence and transcription of Raji Epstein-Barr virus DNA spanning the B95-8 deletion region.

Authors:  B D Parker; A Bankier; S Satchwell; B Barrell; P J Farrell
Journal:  Virology       Date:  1990-11       Impact factor: 3.616

4.  Functional analysis of point mutations in the AAUAAA motif of the SV40 late polyadenylation signal.

Authors:  J Wilusz; S M Pettine; T Shenk
Journal:  Nucleic Acids Res       Date:  1989-05-25       Impact factor: 16.971

Review 5.  Transcription termination and 3' processing: the end is in site!

Authors:  M L Birnstiel; M Busslinger; K Strub
Journal:  Cell       Date:  1985-06       Impact factor: 41.582

6.  The Epstein-Barr virus (EBV) BZLF1 immediate-early gene product differentially affects latent versus productive EBV promoters.

Authors:  S Kenney; J Kamine; E Holley-Guthrie; J C Lin; E C Mar; J Pagano
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

7.  Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer.

Authors:  M A Frohman; M K Dush; G R Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

8.  A simple and very efficient method for generating cDNA libraries.

Authors:  U Gubler; B J Hoffman
Journal:  Gene       Date:  1983-11       Impact factor: 3.688

9.  Transcription of the hepatitis B surface antigen gene in mouse cells transformed with cloned viral DNA.

Authors:  C Pourcel; A Louise; M Gervais; N Chenciner; M F Dubois; P Tiollais
Journal:  J Virol       Date:  1982-04       Impact factor: 5.103

10.  The Epstein-Barr virus early protein EB1 activates transcription from different responsive elements including AP-1 binding sites.

Authors:  G Urier; M Buisson; P Chambard; A Sergeant
Journal:  EMBO J       Date:  1989-05       Impact factor: 11.598

View more
  19 in total

Review 1.  Virus-encoded microRNAs.

Authors:  Adam Grundhoff; Christopher S Sullivan
Journal:  Virology       Date:  2011-01-31       Impact factor: 3.616

Review 2.  Advances in microRNAs: implications for gene therapists.

Authors:  Rebecca T Marquez; Anton P McCaffrey
Journal:  Hum Gene Ther       Date:  2008-01       Impact factor: 5.695

3.  Epstein-Barr virus BHRF1 micro- and stable RNAs during latency III and after induction of replication.

Authors:  Li Xing; Elliott Kieff
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

Review 4.  The role of RNAi and microRNAs in animal virus replication and antiviral immunity.

Authors:  Jennifer L Umbach; Bryan R Cullen
Journal:  Genes Dev       Date:  2009-05-15       Impact factor: 11.361

Review 5.  Viral and cellular microRNAs as determinants of viral pathogenesis and immunity.

Authors:  Eva Gottwein; Bryan R Cullen
Journal:  Cell Host Microbe       Date:  2008-06-12       Impact factor: 21.023

Review 6.  Viruses, microRNAs, and host interactions.

Authors:  Rebecca L Skalsky; Bryan R Cullen
Journal:  Annu Rev Microbiol       Date:  2010       Impact factor: 15.500

7.  The Epstein-Barr virus nuclear protein SM is both a post-transcriptional inhibitor and activator of gene expression.

Authors:  V Ruvolo; E Wang; S Boyle; S Swaminathan
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

Review 8.  The role of 3' end uridylation in RNA metabolism and cellular physiology.

Authors:  Dagmar Zigáčková; Štěpánka Vaňáčová
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-11-05       Impact factor: 6.237

9.  A Genome-Wide Epstein-Barr Virus Polyadenylation Map and Its Antisense RNA to EBNA.

Authors:  Vladimir Majerciak; Wenjing Yang; Jing Zheng; Jun Zhu; Zhi-Ming Zheng
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

10.  Discrete clusters of virus-encoded micrornas are associated with complementary strands of the genome and the 7.2-kilobase stable intron in murine cytomegalovirus.

Authors:  Amy H Buck; Javier Santoyo-Lopez; Kevin A Robertson; Diwakar S Kumar; Martin Reczko; Peter Ghazal
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.